Objectives: We investigated the inward rectifier potassium current (I K1 ), which can be blocked by intracellular Ca 2+ , in heart failure (HF). Methods: We used the whole-cell patch-clamp technique to record I K1 from single rat ventricular myocytes in voltage-clamp conditions. Fluorescence measurements of diastolic Ca 2+ were performed with Indo-1 AM. HF was examined 8 weeks after myocardial infarction (coronary artery ligation). Results: I K1 was reduced and diastolic Ca 2+ was increased in HF cells. The reduction of I K1 was attenuated when EGTA was elevated from 0.5 to 10 mM in the patch pipette and prevented with high BAPTA (20 mM). Ryanodine (100 nM) and FK506 (10 AM), both of which promote spontaneous SR Ca 2+ release from ryanodine receptor (RyR2) during diastole, reproduced the effect of HF on I K1 in normal cells but had no effect in HF cells. The effects of ryanodine and FK506 were not additive and were prevented by BAPTA. Rapamycin (10 AM), which removes FKBP binding proteins from RyR2 with no effect on calcineurin, mimicked the effect of FK506 on I K1 . Cyclosporine A (10 AM), which inhibits calcineurin via cyclophilins, had no effect. In both HF cells and normal cells treated by FK506, the protein kinase C (PKC) inhibitor staurosporine totally restored the inward component of I K1 , but only partially restored its outward component at potentials corresponding to the late repolarizing phase of the action potential (À 80 to À 40 mV). Conclusions: I K1 is reduced by elevated diastolic Ca 2+ in HF, which involves in parallel PKC-dependent and PKC-independent mechanisms. This regulation provides a novel paradigm for Ca 2+ -dependent modulation of membrane potential in HF. Since enhanced RyR2-mediated Ca 2+ release also reduces I K1 , this paradigm might be relevant for arrhythmias related to acquired or inherited RyR2 dysfunction.
Introduction
I K1 has a major role in stabilizing the resting potential of ventricular myocytes near the negative K + equilibrium potential (for review: [1] ). I K1 also carries a transient outward current during the late phase of the action potential (AP) and is a major repolarizing current [1, 2] . Its conductance increases under hyperpolarization (K + entry) and decreases under depolarization (K + exit). Comparatively, much less outward current is passed than inward current. This property, referred to as Finward rectification_, results from depolarization-induced blockade of I K1 channels by polyamines and intracellular cations such as Mg 2+ and Ca 2+ [1, 3, 4] . Although the blocking effect of intracellular Ca 2+ is less potent than that of Mg 2+ , it starts at sub-micromolar concentration and is dose-dependent [4] . Thus, an increase in intracellular Ca 2+ is expected to increase the rectification of I K1 , which may occur during physiological intracellular Ca 2+ transient [4 -7] . Heart failure (HF) is characterized by inefficiency of the heart to pump blood out. It also involves arrhythmia.
Sudden cardiac death due to ventricular tachycardia degenerating into ventricular fibrillation occurs frequently. Fatal arrhythmia involves oscillations of the cellular membrane potential (E m ), referred to as early and delayed afterdepolarizations (EADs and DADs, respectively) depending whether they occur during the AP plateau or after complete repolarization (for review: [8] ). At the cellular level, HF is characterized by abnormal prolongation of AP duration, resulting from an imbalance between depolarizing and repolarizing ionic currents, which provides the substrate for arrhythmia. Down-regulation of the repolarizing transient outward K + current (I to ) is the most consistent change [9 -15] . However, despite controversies among studies [16, 17] , decreases in I K1 and reduced resting E m have been reported in several experimental animal models of HF and in human cells of patients with HF [9 -15,18] . At the molecular level, the basis for reduction of I K1 in HF has been explored to a very limited extent [18] . Changes in expression level of I K1 channels are unlikely [19, 20] .
HF is also characterized by major remodeling of intracellular Ca 2+ cycling. Abnormal Ca 2+ cycling is responsible for depressed contraction, but it also contributes to arrhythmia [8] . It has been proposed that diastolic SR Ca 2+ leak, due in part to defective RyR2, might be central [21, 22] . Local Ca 2+ dynamics and resultant activation of I Na-Ca and other Ca 2+ -sensitive membrane currents are of particular relevance [22, 23] . In the present work, we sought to establish whether a Ca 2+ -dependent mechanism accounts for the reduction of I K1 in HF.
Materials and methods
Wistar rats (Janvier, Le Genest-St-Isle, Fr) were used. The investigation conformed to the guidelines for the Care and Use of Laboratory Animals (NIH, N-. 85-23, revised 1996) and European directives (96/609/EEC).
Post-myocardial infarction model
Myocardial infarction (MI) was induced in 250-280 g male animals by ligation of the left anterior descending coronary artery [11] . Sham-operated animals were submitted to the same treatment except coronary artery ligation. Animals were sacrificed at 8 weeks after surgery. Only post-MI (PMI) hearts with transmural scar were used [11] . Echocardiography (ATL, HDI 3000 equipped with 8.0-MHz phased array transducer) showed that PMI animals (n = 8) had dilated left ventricles with a left ventricular enddiastolic diameter of 9.5 T 0.3 mm (vs 5.7 T 0.6 mm in control rats; mean T SEM; n = 4), and altered systolic function with a left ventricular fractional shortening of 14 T 1% (vs 43 T 2% in control rats). No difference was observed between control and sham-operated rats that had normal cardiac function [11, 24] .
Cell isolation and electrophysiology
Rats were heparinized (0.2 ml, Heparine GIBCO \ 1000 UI/ml) and anaesthetized with sodium pentobarbital (100 mg/kg, Sanofi Santé, France), and ventricular myocytes were enzymatically isolated as described [11, 25] . Cells from the right ventricular free wall, i.e. exclusively in non-infarcted tissues of PMI animals, were used. Whole-cell patch-clamp experiments were performed at room temperature (22 -24 -C) with an Axopatch 200A (Axon instrument, Burlingham, CA, USA). Patch pipettes had resistances of approximately 2 MV. Series resistances were electronically compensated [11, 25] .
For I K1 recording, pipettes were filled with a solution containing (mM): KCl (130), HEPES (25) , ATP-Mg (3), GTP-Na (0.4), EGTA (0.5, unless otherwise noted); pH adjusted to 7.2 with KOH. Myocytes were superfused with a solution containing (mM): NaCl (135), MgCl 2 (1), KCl (4), Glucose (11), HEPES (2), CaCl 2 (1.8); pH adjusted to 7.4 with NaOH. 10 AM tetrodotoxin (TTX) and 2 mM cobalt (Co 2+ ) were added extracellularly to block Na + and Ca 2+ currents, respectively. Current-to-voltage (I -V) relationships were obtained by starting with a HP of À 80 mV with test pulses (1s) varying in the range À 120 mV to + 10 mV applied in steps of 10 mV. As a sign of cellular hypertrophy, membrane capacitance was increased in HF (205.3 T 12.8 pF, n = 30) compared to sham-operated (132.6 T 7.1 pF; n = 6; **p < 0.01) and control animals (126.4 T 6.8 pF; n = 28; **p < 0.01). Amplitudes and I -V relationships of I K1 were indistinguishable between control and sham-operated groups (data not shown). Results obtained in both groups were pooled and referred to as Normal.
Measurements of Ca 2+ transient
Cells were loaded for 30 min at room temperature with Indo-1 AM (10 AM, Molecular Probes, Inc, Oregon, USA). Fluorescence was measured using a multiphotonic microscope (LSM510-LNO, Zeiss, Le Pecq, Fr, coupled to a 5 mW laser, TiSa Mira-Verdi from Coherent, Orsay, Fr). The fluorescences, emitted at 405 and 480 nm following femtosecond laser pulse excitation at 740 nm, were simultaneously recorded in the line-scan mode (1.9 ms per line). Their ratio (F405/F480) was used to determine the qualitative variation (arbitrary unit: AU) of intracellular Ca 2+ ([Ca 2+ ] i ).
Solutions
FK506 (generous gift from Fujisawa Pharmaceutical Co., Ltd, Osaka, Japan), cyclosporin A (CsA; generous gift from Novartis Pharma AG, Basel, Switzerland), rapamycin (A.G. Scientific, INC, San Diego, CA, US) and staurosporine (Sigma, St Quentin Fallavier, France) were prepared as 25 mM stock solutions in DMSO. Ryanodine (Sigma, St Quentin Fallavier, France) was prepared as 10 mM stock solution in distilled H 2 O. Aliquots of the stock solution were diluted to the desired concentrations in the perfusion solution. Vehicle control experiments with DMSO at final concentration of 0.1% showed no effect on I K1 .
Analyses and statistics
Data acquisition and analyses were performed using Pclamp (version 8.1, Axon instruments). Currents were normalized to the cell membrane capacitance. All averaged data are presented as mean T SEM. Statistics were performed using Student's t test (for paired or unpaired samples), and one-way analysis of variance (ANOVA test) when more than two groups were compared, with a Newman -Keuls multiple comparisons test for pairs of values. Differences were considered significant with p less than 0.05 (*p < 0.05). buffering kinetics, the I-V relationships of Normal and HF cells were indistinguishable (Fig. 1C) . BAPTA prevented the flattening observed between À 80 mV and À 40 mV with low EGTA in HF cells. However, the differences in the effects of low and high EGTA and BAPTA were less pronounced on the inward I K1 , measured at À 120 mV, than on the outward current measured at À 60 mV (Fig. 2 ).
Results

Reduction of I
Altogether these results suggested that intracellular free Ca 2+ plays a role in the reduction of I K1 in HF cells.
FK506 and rapamycin reproduced the effects of HF on I K1
FKBP12.6 maintains the RyR2 channel in its closed state. It is a specific receptor of immunosuppressive agents such as FK506 and rapamycin that dissociate the RyR2-FKBP12.6 complex and enhance SR Ca 2+ leak [26 -29] . We used FK506 (10 AM) and rapamycin (10 AM) to assess the effect of RyR2-mediated Ca 2+ release on I K1 . In Normal cells (low EGTA), FK506 and rapamycin reduced I K1 and reproduced the effect of HF on the I -V relationship (Fig.  3A,B) . At À60 mV, FK506 decreased I K1 from 1.18 T 0.09 to 0.57 T 0.07 pA/pF (n = 8; p < 0.05) and rapamycin decreased I K1 from 1.19 T 0.10 to 0.60 T 0.07 pA/pF (n = 5; p < 0.05). However, FK506 had no effect on I K1 when high BAPTA was used in the patch pipette solution (1.25 T 0.06 before vs. 1.16 T 0.07 pA/pF after FK506 at À 60 mV; n = 7; Fig. 3C ). It should be noted that the densities of I K1 in HF cells and in the presence of either FK506 or rapamycin in Normal cells were similar. Moreover, FK506 had no significant effect on I K1 in HF cells (0.66 T 0.09 before vs. 0.53 T 0.13 pA/pF after FK506, n = 3; Fig. 3C ). Rapamycin, which removes FKBPs from the RyR2, but with no effect on calcineurin activity, mimicked the effect of FK506 on I K1 (Fig. 3B,C) . In contrast, cyclosporin A, which inhibits calcineurin via cyclophilins (and not via FKBP), failed to reproduce the effects of both FK506 and rapamycin (Fig.  3C) . At À 60 mV, I K1 was unchanged (1.22 T 0.07 before CsA vs. 1.18 T 0.12 pA/pF after CsA; n = 5). Therefore, the effects of FK506 and rapamycin on I K1 involve FKBPs and are independent of calcineurin activity.
Low ryanodine concentration reproduced the effect of HF on I K1
Ryanodine is a selective and specific ligand of RyRs. Ryanodine leaves the RyRs open in a subconductance state at submicromolar concentration, which results in continuous SR Ca 2+ release [30] . Application of 100 nM ryanodine reduced I K1 in Normal cells, mimicking the effect of HF as shown for I K1 measured at À 60 mV (Fig. 4A,C) . The I -V relationships of I K1 in Normal and HF cells were indistinguishable (Fig. 4A) . Moreover, ryanodine prevented the effect of FK506 (Fig. 4C) , suggesting that the effects of ryanodine and FK506 (and HF) are not additive and are both related to increased Ca 2+ efflux through RyR2. Consistently, the effect of ryanodine was prevented by high BAPTA in the patch-pipette (Fig. 4B,C) . Finally, ryanodine had no effect in HF cells (Fig. 4C) , suggesting that RyR2 activity was already enhanced. Altogether, these results are consistent with the idea that increased SR Ca 2+ release can be involved in the reduction of I K1 during HF.
Effect of staurosporine on I K1 reduced by HF and FK506
Despite larger decrease in its outward component, I K1 was also reduced at hyperpolarized potentials in HF cells, suggesting that the reduction does not exclusively reflect an increase in the rectification of I K1 . There is evidence for an inhibitory effect of PKC on I K1 and for the presence of functional protein kinase C (PKC) phosphorylation sites on molecular entities Kir2.1 and Kir2.2 generating I K1 [31 -33] . We investigated whether Ca 2+ -dependent activation of PKC is responsible for the reduction of I K1 in HF cells. We incubated cardiac cells with the PKC inhibitor staurosporine (10 AM) for 30 min prior to and during the experiments. In Normal cells dialysed with 0.5 mM EGTA, staurosporine had no effect on basal I K1 : the density of I K1 was 1.19 T 0.08 pA/pF (n = 6) (versus 1.17 T 0.07 pA/pF in control conditions; n = 12) at À 60 mV, and À 12.6 T 1.0 pA/pF (n = 6) (versus À 12.9 T 0.7 pA/pF in control conditions; n = 12) at À 120 mV. In HF cells, staurosporine prevented the reduction of I K1, totally at À 120 mV and partially (50%) at À 60 mV (Fig. 5A) . Therefore, the reduction of I K1 in HF involves a PKC-independent mechanism, exclusive at hyperpolarized potentials, in addition to a PKC-independent Ca 2+ block. Staurosporine had similar effects on FK506-induced reduction in I K1 (Fig. 5B) .
Discussion
This study establishes a novel paradigm for Ca 2+ sensing repolarization, linking elevated intracellular Ca 2+ to reduced I K1 during HF in rat ventricular cells. We also show that enhanced Ca 2+ release through RyR2 inhibits I K1 . These effects are mediated in part by PKC and, possibly, by a direct effect of Ca 2+ on the inward rectification at voltages corresponding to the AP late phase. Ca 2+ -dependent reduction of I K1 might therefore provide a substrate for arrhythmia.
RyR2 hyperactivity reduces I K1 in Normal cells
Membrane depolarization results in fine in opening of RyR2 and massive Ca 2+ release from the SR to activate contraction. SR Ca 2+ release has important feedback to modulate membrane potential via Ca 2+ sensitive ionic currents, including I CaL and the inward I Na-Ca . We now establish a link between spontaneous activity of RyR2 and [30] , and FK506/rapamycin, that increase RyR2 frequency of openings [27] and mean open lifetime [26] , reduced I K1 . This effect was prevented when intracellular Ca 2+ was buffered with high BAPTA. The nonadditivity of the effects of ryanodine and FK506 suggested a genuine effect of RyR2-mediated SR Ca 2+ -release on I K1 . The reduction of I K1 seems to involve both PKCdependent and PKC-independent mechanisms. FK506 is known to increase Ca 2+ sparks frequency and/or duration as well as diastolic Ca 2+ in rat ventricular cells [26, 27, 34, 35] . Its effects were partially antagonized by the PKC inhibitor staurosporine. This finding is consistent with reported inhibitory effects of PKC both on native I K1 and recombinant Kir2.1 and Kir2.2 channels [31 -33] . Interestingly, staurosporine abolished the effect of FK506 of I K1 totally at hyperpolarized voltages but only partially (less than 50%) at À 60 mV, implying that another effect is involved. Indeed, a strong inward rectification induced by FK506 persisted at potentials corresponding to the late repolarizing phase of the AP (À 80 mV to À 40 mV). This staurosporine-resistant component might reflect an effect of increased intracellular Ca 2+ on the rectification of I K1 , consistently with the previously reported depolarization-induced blockade of I K1 by Ca 2+ [4 -7] . The localization of I K1 channels (and their corresponding molecular entities Kir2.1 and Kir2.2) close to RyR2 in the T-tubules provide a physical basis for localized effects of SR Ca 2+ release on I K1 [36, 37] .
Involvement in HF:
link with elevated intracellular Ca 2+ and RyR2 activity I K1 is reduced in various ischemic and non-ischemic mammalian, including human, models of HF [9 -15,18,23,38,39] . This reduction is not explained by changes in Kir2.1 level expression [19, 20] . We now show that the reduction of I K1 (up to 50%; see also [23] Diastolic SR Ca 2+ leak, due in part to defective RyR2, might be central in HF [21, 22] . Although attempts to evidence altered RyR2 gating properties in HF have not been successful in intact cells (for review: [42] ), the reduction of I K1 in HF cells might involve altered RyR2 activity. Indeed, the effect of HF on I K1 was reproduced by applying FK506 or rapamycin on Normal cells. These drugs can mimic the effect of HF on RyR2 activity by dissociating the RyR2-FKBP12.6 complex [26] . Moreover, ryanodine and FK506, that both enhance Ca 2+ efflux through RyR2, had no additional effect in HF cells. Our findings are therefore consistent with the concept that Ca 2+ efflux through RyR2, due to instability or decrease in the FKBP12.6-RyR2 complex in HF cells [21, 27, 43, 44] or induced pharmacologically [26 -28] , promotes a reduction of I K1 . This reduction occurs via a PKCdependent decrease, the exclusive mechanism at hyperpolarized potentials, in addition to a PKC-independent Ca 2+ -dependent block of I K1 at voltages corresponding to late AP repolarization. Future studies should aim at understanding how changes in Ca 2+ sparks gating properties and in local Ca 2+ are related to decreased IK1.
A novel paradigm for arrhythmia in HF and RyR2-related genetic diseases
How reduced I K1 destabilizes E m and contributes to the genesis of DADs in HF has not been completely elucidated. It was shown that reduced I K1 and increased inward I Na-Ca are involved together [23] . Indeed, reduced I K1 allows a given I Na-Ca to produce greater depolarization (the ratio I K1 / I Na-Ca decreases). It is also well-accepted that spontaneous SR Ca 2+ release by RyR2 during diastole initiates arrhythmogenic inward I ti and, thereby, DADs [23,45 -48] . We now establish that SR-Ca 2+ release through the RyR2 might affect not only I Na-Ca but also I K1 : I K1 is reduced and, at the same time, a transient inward I Na-Ca is expected to extrude Ca 2+ . The two mechanisms are likely to act synergistically to both destabilize E m and prolong the AP with a ratio I K1 / I Na-Ca highly favorable for triggered arrhythmia. The Ca 2+ -dependent effects on I K1 might also be highly depend on the pacing rate, as suggested from the effect of FK506 on E m [26, 27, 34, 35] .
The paradigm described in the present paper, linking RyR2 activity and elevated intracellular Ca 2+ to reduced I K1 in HF, may also operate in non-failing hearts. Ventricular arrhythmias and sudden cardiac death have been related to enhanced activity of RyR2 mutants in inherited diseases such as catecholamine-induced polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia/cardiomyopathy type 2 (ARVD2) (for review: [49] ). FKBP12.6 deficiency and defective RyR2 activity, possibly related to exercise-induced activation of the sympathetic nervous system and increased PKA phosphorylation of RyR2 in the case of CPVT, have been proposed to be the link. For example, FKBP12.6 deficient mice exhibit exercise-induced ventricular arrhythmias -mostly DADssimilar to those observed in CPVT. We emphasize that Ca 2+ -dependent reduction in I K1 related to RyR2 hyperactivity provides an interesting framework through which to understand arrhythmia related to RyR2 channelopathy.
In summary, I K1 is reduced during HF in rat ventricular cells. This reduction reflects a Ca 2+ -dependent decrease in the functional activity of the corresponding channel protein in relation with elevated intracellular Ca 2+ . This effect was reproduced in Normal cells following pharmacological enhancement of spontaneous RyR2 activity. The reduction involves both PKC-dependent decrease and Ca 2+ -dependent block of I K1 . These effects are expected to result in destabilization of the resting E m , prolongation of late phase of the AP, and, thereby, in increased propensity for arrhythmia. Our results might provide new insights into the cellular mechanisms by which altered RyR2 activity is involved in arrhythmia.
